Showing results (51-60 of 91) with videos related to
Sort By:
Pageof 10
JAMA Neurology|December 2, 2014
Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment responseFrank Leypoldt, Romana Höftberger, Maarten J Titulaer, et al.Plos One|May 11, 2018
Specific serum and CSF microRNA profiles distinguish sporadic behavioural variant of frontotemporal dementia compared with Alzheimer patients and cognitively healthy controlsJohannes Denk, Felix Oberhauser, Johannes Kornhuber, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|January 21, 2022
Don't forget about tau: the effects of ApoE4 genotype on Alzheimer's disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment-data from the Dementia Competence NetworkGloria S Benson, Chris Bauer, Lucrezia Hausner, et al.Journal of Psychopharmacology (Oxford, England)|June 1, 2018
A randomized Phase 2 study to evaluate the orexin-2 receptor antagonist seltorexant in individuals with insomnia without psychiatric comorbidityPeter De Boer, Wayne C Drevets, Hany Rofael, et al.Journal of Proteome Research|February 27, 2020
Targeted Mass Spectrometry Suggests Beta-Synuclein as Synaptic Blood Marker in Alzheimer's DiseasePatrick Oeckl, Steffen Halbgebauer, Sarah Anderl-Straub, et al.Journal of Neurology, Neurosurgery, and Psychiatry|December 31, 2020
Beta-synuclein in cerebrospinal fluid as an early diagnostic marker of Alzheimer's diseaseSteffen Halbgebauer, Patrick Oeckl, Petra Steinacker, et al.Neurobiology of Aging|December 2, 2014
Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's typeJulius Popp, Steffen Wolfsgruber, Isabella Heuser, et al.Journal of Neurochemistry|January 27, 2007
Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 loadJens Wiltfang, Hermann Esselmann, Mirko Bibl, et al.Alzheimer'S Research & Therapy|April 27, 2018
A language-based sum score for the course and therapeutic intervention in primary progressive aphasiaElisa Semler, Sarah Anderl-Straub, Ingo Uttner, et al.Frontiers in Aging Neuroscience|February 15, 2018
A Modified Reading the Mind in the Eyes Test Predicts Behavioral Variant Frontotemporal Dementia Better Than Executive Function TestsMatthias L Schroeter, Sarah Pawelke, Sandrine Bisenius, et al.Pageof 10